Navigation Links
Drug Users Are 'Super-Spreaders' of Hepatitis C, Study Finds
Date:1/31/2013

THURSDAY, Jan. 31 (HealthDay News) -- Each injection drug user with hepatitis C is likely to infect about 20 other people, and half of those transmissions occur in the first two years after the initial infection, new research shows.

The findings indicate that early diagnosis and treatment of hepatitis C in injection drug users -- called "super-spreaders" -- could prevent many cases of hepatitis C, the researchers said.

The hepatitis C virus is spread through contact with infected blood, having sex with an infected person and from mother to baby during childbirth. Hepatitis C can lead to scarring of the liver or liver cancer. Some patients require a liver transplant. There is no vaccine for the disease.

The researchers combined epidemiological and molecular data to determine how hepatitis C spreads in a population.

"For the first time we show that super-spreading in hepatitis C is led by intravenous drug users early in their infection," study author Gkikas Magiorkinis, of the zoology department at the University of Oxford in England, said in a university news release.

"Using this information, we can hopefully soon make a solid argument to support the scaling-up of early diagnosis and antiviral treatment in drug users," Magiorkinis said. "Helping these people and stopping the spread of hepatitis C is our ultimate target."

The study was published Jan. 31 in the journal PLoS Computational Biology.

Up to 180 million people worldwide are infected with hepatitis C, but many don't know it and go undiagnosed for more than 10 years.

"Working out how many people are likely to be infected by each 'super-spreader' of hepatitis C, as well as how soon they will be infected, has been a puzzle for over 20 years," Magiorkinis said.

"Our research has resolved this issue and paves the way for a modeling study to show what kind of public health interventions could really make a difference," he added. He said their approach should also be useful to those studying HIV.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about hepatitis C.

-- Robert Preidt

SOURCE: University of Oxford, news release, Jan. 31, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
2. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or Other Serious Medical Issues to Call the Johnson Law Group-ASAP
3. Bundlevid.Me: New Apple iPhone App Bundlevid Brings Easy Video Journaling to iPhone Users
4. US Drug Watchdog Now Urges Users of Yaz or Yasmin Birth Control Pills Who Suffered A Life Threatening Medical Problem To Call The Johnson Law Group-Immediately
5. The US Drug Watchdog Now Urges Users Of The Birth Control Pills Yaz-Yasmin to Contact The Johnson Law Group For a Legal Review if They Developed Severe Medical Problems
6. New ChairMaster™ Fitness Chair Lets Users Sit and Get Fit
7. Voice Activated PDA for Blind and Low Vision Users from LS&S Now Offered by Rehabmart
8. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Stroke, Blood Clots, or a Heart Attack to Call the Johnson Law Group for a Legal Review
9. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
10. myMEDholiday Comes up with a New Highly Credible Informative Website for Users Looking for Affordable Healthcare Centers Abroad
11. Kids With Autism Common Users of ERs, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Users Are 'Super-Spreaders' of Hepatitis C, Study Finds
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of traumatic ... to conduct a survey that takes a closer look at cases of TBI being ... and causes of TBI among the aging population, and identifies the challenges associated with ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed ... their network of laboratory service centers across the country. Launched in April of 2015, ... the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Club at ... the prestigious Distinguished Emerald Club of the World award, as determined by the ... of the most respected trade publications serving private clubs. , “We’d like to ...
(Date:2/10/2016)... ... 10, 2016 , ... Workrite Ergonomics, who is celebrating their 25th year of ... to being an internationally recognized leader in their industry. , "We are very proud ... President of Workrite. “Workrite recognized the importance of good ergonomics before most of ...
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. ... are delighted to welcome a new addition to their growing practice. Beginning this ... as a nurse practitioner performing cosmetic procedures including injectables, fillers and ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... CERS ), Medivation, Inc. (NASDAQ: ... Celldex Therapeutics, Inc. (NASDAQ: CLDX ). --> ... Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, Inc. (NASDAQ: ... Designations become vitally important in the development of targeted treatment ... biologics which are defined as those intended for the safe ...
(Date:2/10/2016)... , February 10, 2016 Antibacterial Drugs ... Forecast 2015 - 2023 ", reveals that the global antibacterial ... from 2015 to 2023 owing to patent expiries of blockbuster ... of 1.30% during the forecast period, the value is anticipated ... in 2023. --> Antibacterial Drugs Market - Global ...
(Date:2/10/2016)... February 10, 2016 --> ... research report "Pharmaceutical Packaging Equipment Market by Package Type ... Serialization), by Product Type (Tablet, Powder, Cream, Syrup, Aseptic ... MarketsandMarkets, studies the global market during the forecast period of ... at a CAGR of 6.9% during the forecast period ...
Breaking Medicine Technology: